Effects of Efavirenz for the Treatment of HIV on the Basis of Genetic Polymorphisms
Introduction: The CYP2B6 is a liver enzyme that is involved in the metabolism of several drugs including Efavirenz, which is one of the mainstay treatments for Acquired Immunodeficiency Syndrome (AIDS), caused by the Human Immunodeficiency Virus (HIV). Polymorphisms in the CYP2B6 gene determines the...
Main Authors: | Brighty Elizabeth Kurian, Swamy Miryala, Srikrishna Raghavendra Boddu |
---|---|
Format: | Article |
Language: | English |
Published: |
JCDR Research and Publications Private Limited
2022-04-01
|
Series: | Journal of Clinical and Diagnostic Research |
Subjects: | |
Online Access: | https://www.jcdr.net/articles/PDF/16261/52614_F(SS)_PF1(SG_SL_SHU)_PFA(Pr_SG_KM)_PN(KM).pdf |
Similar Items
-
A mixed method assessment of the fertility preferences of clients using antiretroviral therapy in Ilorin, Nigeria – A descriptive cross-sectional survey
by: Adedayo Ayodele Aderibigbe, et al.
Published: (2024-01-01) -
Efficacy of a mobile phone-based intervention on health behaviors and HIV/AIDS treatment management: randomized controlled trial
by: Tran, Bach Xuan, et al.
Published: (2023) -
Effect of anthropometric and sociodemographic variables on physical activity levels of people living with human immunodeficiency virus/acquired immunodeficiency syndrome on highly active antiretroviral therapy
by: Jane Nwanneka Anikpe, et al.
Published: (2023-01-01) -
A Retrospective Cohort Study on the Risk of Kidney Disease in HIV Positive Individuals Receiving Tenofovir Based Regimens
by: Vikash Khandelia, et al.
Published: (2022-06-01) -
AIDS incidence trends at presentation and during follow-up among HIV-at-risk populations: a 15-year nationwide cohort study in Taiwan
by: Chun-Yuan Lee, et al.
Published: (2018-05-01)